Kalanick-Backed Startup Kareo to Merge With Health-Care IT Firm
(Bloomberg) -- Closely held health-care information technology firms PatientPop and Kareo are merging in a deal that, according to a person with knowledge of the matter, will value the combined company at $1 billion including debt.
The merged company will be called Tebra, according to a statement.
Existing Kareo investor Golub Capital will contribute $65 million in growth financing to support the merger. Kareo's board members include Uber Technologies Inc. co-founder Travis Kalanick, its website shows. Kalanick won't join the merged Tebra's board but will remain an investor and adviser to the company, a representative for Tebra said.
The combined company will have about 1,000 employees supporting more than 100,000 health-care providers serving more than 85 million patients in the U.S., according to the statement.Â
Kareo Chief Executive Officer Dan Rodrigues will run the combined company as CEO while PatientPop's co-CEOs, co-founders Luke Kervin and Travis Schneider, will serve as Tebra's chief innovation officer and chief corporate development officer.Â
Based in Irvine, California, Kareo provides software that supports electronic medical records and billing. PatientPop, also based in Southern California in Santa Monica, makes appointment booking tools and products that help patients find doctors.Â
Silver Lake Waterman, a fund that focuses on investing in companies before they go public, according to Silver Lake's website, is a backer of Kareo.
JPMorgan Chase & Co. advised Kareo on the deal.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.